Dialybrid is a company headquartered in Italy.
Dialybrid develops and commercializes hybrid arteriovenous vascular grafts for hemodialysis using a proprietary Silkothane® technology combining silk fibroin and polyurethane.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.